Pulsed Field Ablation Offers Breakthrough in Treatment of Atrial Fibrillation
By HospiMedica International staff writers Posted on 27 May 2022 |
Catheter ablation has long been recognized as an effective treatment for a wide variety of cardiac arrhythmias, but the therapy runs a risk of damage to surrounding tissues. Now, pulsed field ablation (PFA) is emerging as a novel, non-thermal energy source that may offer a safer alternative to conventional catheter ablation technologies. PFA delivers ultrashort, high-voltage pulses to create lesions on targeted tissue. This mechanism is also known as electroporation because it causes temporary pore-like openings in cell walls, leading to death by apoptosis. The frequency of the pulses can be adjusted to target specific proteins within cell membrane, leaving other types of tissue unharmed.
Previously used in oncology to destroy specific types of tumors or to increase tumor permeability to chemotherapy drugs, PFA has recently been adapted for catheter ablation by a number of manufacturers. European regulators approved the first such device in January 2021, but the technology remains investigational in the U.S. NYU Langone (New York, NY, USA) is currently conducting clinical trials of three different PFA cardiac ablation devices in patients with atrial fibrillation.
Across the three trials testing devices developed by Medtronic, Farapulse, and Biosense Webster, primary outcomes include primary adverse events such as atrial-esophageal fistula and cardiac tamponade/perforation within seven days, and freedom from documented atrial arrhythmia, atrial tachycardia, or atrial flutter for up to one year. Secondary outcomes include the number of patients who achieve acute procedural success, defined as confirmation of entrance block in targeted atrial pulmonary veins after adenosine/isoproterenol challenge, and change in quality of life after ablation.
PFA could replace radiofrequency and cryoablation as the premier energy source for cardiac ablation. Eventually, it could be adapted beyond atrial fibrillation to other arrhythmias, including those involving the ventricles. However, numerous questions about the new technology remain, including how durable are the lesions that PFA produces, the safety compared with conventional counterparts, and which of the available catheters is optimal for a given application, such as paroxysmal versus persistent atrial fibrillation.
“With traditional energy sources, we spend much of our time trying to avoid collateral damage to the nerves, blood vessels, lungs, or esophagus,” said Larry A. Chinitz, MD, director of the Heart Rhythm Center. “PFA offers the hope for an energy source that is instantaneous, efficacious, and specific to the heart.”
Related Links:
NYU Langone
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery